Linsheng Zhan

Dr. Linsheng Zhan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2021 in Advanced Materials
Verified
Journal Article
Open access
PDF file
QZQianqian Zhou
Qianqian Zhou
HGHongjing Gu
Hongjing Gu
SSSujing Sun
Sujing Sun
YZYulong Zhang
Yulong Zhang
YHYangyang Hou
Yangyang Hou
LZLinsheng Zhan
Linsheng Zhan
Dendritic cell (DC) vaccines are used for cancer and infectious diseases, albeit with limited efficacy. Modulating the formation of DC–T‐cell synapses may greatly increase their efficacy. The effects of graphene oxide (GO) nanosheets on DCs and DC–T‐cell synapse formation are evaluated. In particular, size‐dependent interactions are observed between GO nanosheets and DCs. GOs with diameters of >1 µm (L‐GOs) demonstrate strong adherence to the DC surface, inducing cytoskeletal reorganization via the RhoA‐ROCK‐MLC pathway, while relatively small GOs (≈500 nm) are predominantly internalized by DCs. Furthermore, L‐GO treatment enhances DC–T‐cell synapse formation via cytoskeleton‐dependent membrane positioning of integrin ICAM‐1. L‐GO acts as a “nanozipper,” facilitating the aggregation of DC–T‐cell clusters to produce a stable microenvironment for T cell activation. Importantly, L‐GO‐adjuvanted DCs promote robust cytotoxic T cell immune responses against SARS‐CoV‐2 spike 1, leading to >99.7% viral RNA clearance in mice infected with a clinically isolated SARS‐CoV‐2 strain. These findings highlight the potential value of nanomaterials as DC vaccine adjuvants for modulating DC–T‐cell synapse formation and provide a basis for the development of effective COVID‐19 vaccines.

Verified
Journal Article
Open access
PDF file
GGGao Gao
Gao Gao
QZQianqian Zhou
Qianqian Zhou
YZYulong Zhang
Yulong Zhang
SSSujing Sun
Sujing Sun
LLLiping Lv
Liping Lv
LZLinsheng Zhan
Linsheng Zhan
The effective cryopreservation of mesenchymal stem cells (MSCs) is indispensable to the operation of basic research and clinical transplantation. The prevalent protocols for MSC cryopreservation utilize dimethyl sulfoxide (DMSO), which is easily permeable and able to protect MSCs from cryo-injuries, as a primary cryoprotectant (CPA). However, its intrinsic toxicity and adverse effects on cell function remain the bottleneck of MSC cryopreservation. In this work, we cryopreserved human umbilical cord mesenchymal stem cells (UCMSCs) using zwitterionic betaine combined with electroporation without any addition of DMSO. Betaine was characterized by excellent compatibility and cryoprotective properties to depress the freezing point of pure water and balance the cellular osmotic stress. Electroporation was introduced to achieve intracellular delivery of betaine, intending to further provide comprehensive cryoprotection on UCMSCs. Compared with DMSO cryopreservation, UCMSCs recovered from the protocol we developed maintained the normal viability and functions and reduced the level of reactive oxygen species (ROS) that are harmful to cell metabolism. Moreover, the in vivo distribution of thawed UCMSCs was consistent with that of fresh cells monitored by a bioluminescence imaging (BLI) system. This work opens a new window of opportunity for DMSO-free MSC cryopreservation using zwitterionic compounds like betaine combined with electroporation.

28 August 2023 in Advanced Science
Verified
Journal Article
Open access
CLChenyan Li
Chenyan Li
YHYangyang Hou
Yangyang Hou
MHMinwei He
Minwei He
LLLiping Lv
Liping Lv
YZYulong Zhang
Yulong Zhang
LZLinsheng Zhan
Linsheng Zhan
Immunotherapy using dendritic cell (DC)‐based vaccination is an established approach for treating cancer and infectious diseases; however, its efficacy is limited. Therefore, targeting the restricted migratory capacity of the DCs may enhance their therapeutic efficacy. In this study, the effect of laponite (Lap) on DCs, which can be internalized into lysosomes and induce cytoskeletal reorganization via the lysosomal reprogramming–calcium flicker axis, is evaluated, and it is found that Lap dramatically improves the in vivo homing ability of these DCs to lymphoid tissues. In addition, Lap improves antigen cross‐presentation by DCs and increases DC‐T‐cell synapse formation, resulting in enhanced antigen‐specific CD8+ T‐cell activation. Furthermore, a Lap‐modified cocktail (Lap@cytokine cocktail [C‐C]) is constructed based on the gold standard, C‐C, as an adjuvant for DC vaccines. Lap@C‐C‐adjuvanted DCs initiated a robust cytotoxic T‐cell immune response against hepatitis B infection, resulting in > 99.6% clearance of viral DNA and successful hepatitis B surface antigen seroconversion. These findings highlight the potential value of Lap as a DC vaccine adjuvant that can regulate DC homing, and provide a basis for the development of effective DC vaccines.

1 April 2025 in Microbial Pathogenesis
Verified
Journal Article
Closed access
XLXingzhao Liu
Xingzhao Liu
YLYipu Li
Yipu Li
MHMinwei He
Minwei He
YZYan Zhao
Yan Zhao
CLChenyan Li
Chenyan Li
LZLinsheng Zhan
Linsheng Zhan

1 April 2026 in Cell Death & Differentiation
Verified
Journal Article
Closed access
MHMinwei He
Minwei He
YZYan Zhao
Yan Zhao
YLYipu Li
Yipu Li
DZDa Zhang
Da Zhang
MZMan Zhao
Man Zhao
LZLinsheng Zhan
Linsheng Zhan

31 January 2022
Verified
Report
Open access
TUThe Affiliated Xiangshan Hospital of Wenzhou Medical University
The Affiliated Xiangshan Hospital of Wenzhou Medical University
CZchen zhi
chen zhi
BHBo Hong
Bo Hong
SHSaiYue Han
SaiYue Han
CZChunNa Zhou
ChunNa Zhou
HLHongYa Lai
HongYa Lai
INPLASY202210136 Sarcopenia and mild cognitive impairment: A systematic review and meta-analysis Keywords: Sarcopenia; mild cognitive impairment; MCI. Download PDF – 202210136 Review Status: …